Is it premature to recommend selenium supplementation?

Wiener Klinische Wochenschrift

Volumn 109, Issue 16, 1997, Pages 659-660

  Partyka, Lukasz ^a   Aghajanian, Arsineh Arakil ^b   Sinzinger, Helmut ^b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; SELENIUM;

ANEMIA; CANCER SUSCEPTIBILITY; CHRONIC KIDNEY FAILURE; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; GLUTATHIONE METABOLISM; HUMAN; LETTER; MYOPATHY; OXIDATION REDUCTION REACTION; SELENIUM DEFICIENCY; VITAMIN INTAKE;

ANTIOXIDANTS; HUMANS; RENAL DIALYSIS; SELENIUM;

EID: 0030757738     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Saint-Georges MD, Bonnefont DJ, Bourely BA, Jaudon MC, Cereze P, Chaumeil P, et al (1989) Correction of selenium deficiency in hemodialyzed patients. Kidney Int [Suppl] 27: S274-277
2. McGrath LT, Douglas AF, McClean E, Brown JH, Doherty CC, Johnston GD, et al (1995) Oxidative stress and erythrocyte membrane fluidity in patients undergoing regular dialysis. Clin Chim Acta 235: 179-188
3. Richard MJ, Ducros V, Foret M, Arnaud J, Coudray C, Fusselier M, et al (1993) Reversal of selenium and zinc deficiencies in chronic hemodialysis patients by intravenous sodium selenite and zinc gluconate supplementation. Time-course of glutathione peroxidase repletion and lipid peroxidation decrease. Biol Trace Elem Res 39: 149-159
4. Koenig JS, Fischer M, Bulant E, Tiran B, Elmadfa I, Druml W (1997) Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation. Wien Klin Wochenschr 109: 13-19
5. Leitinger N, Pirich C, Blazek I, Endler G, Sinzinger H (1996) Decreased susceptibility of low-density lipoproteins to in vitro oxidation after dextran-sulfate LDL-apheresis treatment. Atherosclerosis 126: 305-312
6. Pirich C, Tatzber F, Sinzinger H (1997) Long-term effect of LDL-apheresis on LDL-oxidation (submitted)
7. Esterbauer H, Schmidt R, Hayn M (1997) Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis. Adv Pharmacol 38: 425-456
8. Milly K, Wit L, Diskin C, Tulley R (1992) Selenium in renal failure patients. Nephron 61: 139-144
9. Eisenmann CJ, Miller RK (1995) The effect of selenium compounds (selenite, selenate, ebselen) on production of thromboxane and prostacyclin by human term placenta in vitro. Toxicol Appl Pharmacol 135: 18-24